CONATUS PHARMACEUTICALS INC. (NASDAQ:CNAT) Files An 8-K Termination of a Material Definitive AgreementItem 1.02
On December 19, 2016, Conatus Pharmaceuticals Inc. (the “Company”) provided written notice to MLV & Co. LLC (“MLV”) of termination of the parties’ At Market Issuance Sales Agreement dated August 14, 2014 (the “Sales Agreement”). Under the Sales Agreement, the Company could sell from time to time, at its option, up to an aggregate of $50.0 million of shares of its common stock through MLV, as sales agent. The termination will become effective ten days after the Company’s written notice to MLV, or December 29, 2016.
The foregoing description of the Sales Agreement is qualified in its entirety by reference to the complete text of the Sales Agreement, a copy of which was filed as Exhibit 1.2 to the Company’s Registration Statement on Form S-3, filed with the Securities and Exchange Commission on August 14, 2014 (No. 333-198142).
About CONATUS PHARMACEUTICALS INC. (NASDAQ:CNAT)
Conatus Pharmaceuticals Inc. is a biotechnology company. The Company focuses on the development and commercialization of medicines to treat liver disease. The Company operates through commercialization and development of pharmaceutical products segment. The Company is engaged in developing emricasan, which is an orally active pan-caspase protease inhibitor for the treatment of patients with chronic liver disease. Emricasan has the potential to interrupt the progression of liver disease and provide treatment options in multiple areas of liver disease. Emricasan is designed to slow or halt the progression of chronic liver disease caused by fibrosis and cirrhosis. Emricasan works by inhibiting caspases, which are a family of related enzymes that plays as modulators of critical cellular functions, including functions that result in apoptosis and inflammation. CONATUS PHARMACEUTICALS INC. (NASDAQ:CNAT) Recent Trading Information
CONATUS PHARMACEUTICALS INC. (NASDAQ:CNAT) closed its last trading session up +0.05 at 1.96 with 1,518,579 shares trading hands.